Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Search Results (204)

Click the Why column to see why an item matched the search.

Randolph, TheodorePerson Why?
Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry.Academic Article Why?
Chemistry, PharmaceuticalConcept Why?
Carpenter, JohnPerson Why?
Henen, MorkosPerson Why?
Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics.Academic Article Why?
Combinatorial drug discovery: which methods will produce the greatest value?Academic Article Why?
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.Academic Article Why?
Electrochemical determination of dissolution rates of lyophilized pharmaceutical formulations.Academic Article Why?
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.Academic Article Why?
Rapid Quantification of Protein Particles in High-Concentration Antibody Formulations.Academic Article Why?
Common excipients impair detection of protein aggregates during sedimentation velocity analytical ultracentrifugation.Academic Article Why?
Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist.Academic Article Why?
Editorial for Virtual Issue on Polymer Bioconjugates in Biology and Medicine.Academic Article Why?
Enzyme-mediated redox initiation for hydrogel generation and cellular encapsulation.Academic Article Why?
Per Page    Page  of 14last Nextnext
Search Criteria
  • Pharmaceutical Chemistry
Filter by Type

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)